Skip to main content
Search

# Series C financing round

1 related articles

Subscribe to updates
  1. Venture Capital

    Isomorphic Labs announces a $5 billion Series C to move its first therapeutic programs toward clinical trials

    Isomorphic Labs announced a $5 billion Series C round co-led by Greenoaks and Sequoia Capital, with new investors including a16z, continued significant investment from Alphabet, and participation from all existing investors. The company says the capital will fund further development of its proprietary drug-design engine IsoDDE, expansion of its internal and partnered drug-candidate portfolio, and construction of global infrastructure for AI-driven bioengineering and clinical translation. Isomorphic also says its internal oncology and immunology programs and partnered programs have produced positive preclinical results and are paving the way for its first therapeutic programs to enter clinical trials.

You’re all caught up